The European Commission is rewriting its merger guidelines for the first time in twenty years. And one idea runs through the entire document, stated explicitly: understanding the rationale of the merger and the business model of the parties is central to the assessment.
That is not a footnote. It is a guiding principle.
For lawyers advising on mergers before the Commission, this matters. Not because the legal framework has become less important, but because the financial and economic layer underneath it has become unavoidable, especially in complex transactions.
The Business Model Is Now Part of the Framework
The 2004 guidelines were built around market shares and concentration levels. Those remain relevant. But the new framework goes further.
The Commission will now formally assess parameters of competition that go beyond price: innovation, investment intensity, R&D spending, profit margins, sustainability, and the dynamic competitive potential of the merging firms. These are questions about what a company actually does, how it generates value, and where it is going.
The answers are not in the legal databases. They are in the annual reports, the investor presentations, the earnings calls, and the capital allocation decisions that companies disclose every quarter.
Lawyers who cannot read those documents will find it harder to advise clients on how the Commission is likely to assess their transaction, and harder to build the arguments that the new framework rewards. In other words, if the business model supports your argument, your chances of success increases, if not, it won’t matter what you say.
Efficiencies: A Real Defence, but a High Bar
One of the most significant shifts in the new guidelines is the treatment of efficiencies. The Commission devoted more than ten pages to explaining how efficiencies will be assessed. That is not an accident.
Efficiencies can now play a meaningful role in clearing a merger that might otherwise raise concerns. It is worth mentioning the balancing test, if benefits outweigh harms, the merger will be cleared. But to be accepted, they must meet three conditions: they must be verifiable, merger-specific, and passed on to consumers.
The evidence the Commission will look at is telling. Internal documents. Business and integration plans. Public announcements to investors by listed companies on expected synergies. Independent pre-merger studies prepared before the start of negotiations.
That last point deserves attention. Studies prepared independently, before negotiations begin, carry more weight. Studies prepared after the deal is announced, by experts hired for the purpose, carry less.
This changes the preparation timeline. Lawyers advising clients on potential transactions need to understand the financial logic of the deal early, not after the notification is filed. If the synergy claims in the notification diverge from what the company told its investors before the deal was announced, the Commission will notice. Financial filings and investor communications are public. The Commission reads them.
The practical implication is straightforward: lawyers need to be able to distinguish real synergies from wishful thinking. If the parties in a €1 billion deal state that they expect revenue synergies over €500 million in two years, that is most likely debatable. That requires understanding the business model well enough to know what is achievable and what is not.
Financial Indicators Are Becoming Standard Merger Vocabulary
The new guidelines introduce financial indicators into the merger assessment in ways that will change the conversations lawyers have with clients and with the Commission.
Profit margins are now explicitly listed as indicators of market power. High margins suggest a firm faces limited competitive pressure. If your client has high margins, the Commission will ask why. The answer requires financial context, not just legal argument. But we do not yet know what profit margins we are talking about, net Profits, EBITDA, ROCE?
Target valuation relative to turnover is cited as a signal of dynamic competitive potential. A high acquisition price compared to current revenues tells the Commission something about what the buyer believes the target is worth strategically. That belief needs to be explained, and explained in financial terms.
R&D spending features prominently as a proxy for innovation capability. The guidelines list patent citations, R&D headcount, innovation output targets, and access to competitively significant inputs as relevant factors. Companies that invest heavily in research and development will need to present that investment as evidence of competitive strength, not just cost.
While the Commission focuses on R&D spending to prove innovation, we noticed one gap worth noting: CAPEX is not explicitly referenced in the guidelines. But in our view, the analytical logic points in that direction. A company investing significant capital expenditure specifically to develop a new product or enter a new market is doing something the guidelines care about — even if the term does not appear in the text. The guidelines leaves the door open for other metrics that can prove dynamic innovation, but it is important to understand what evidence a company may bring to show its commitment to innovation.
More Flexibility Means More Economic Analysis
The new framework introduces significant flexibility in how the Commission assesses mergers. Dynamic effects, long-term impact, innovation competition, investment incentives, these are all now formally in play.
The language throughout the guidelines points toward a more economics-heavy merger process. Economic experts will play a larger role.
But economic analysis alone is not enough. The Commission has been clear, including in its decisional practice, that paid economic reports built on assumptions that favour the parties carry less weight than objective market data. Audited financial statements, analyst reports, and investor documents are harder to dismiss.
This creates a specific challenge for lawyers. The economist prepares the model. The lawyer needs to understand it well enough to translate it into a legal argument and to know when the model diverges from what the financial markets are actually saying about the company. Bridging that gap is the lawyer’s job. It requires financial literacy, not just legal expertise.
The Innovation Shield: A New Tool, With Limits
The guidelines introduce a presumption that acquisitions of R&D projects or start-ups are unlikely to raise competition concerns, if certain conditions are met.
This is a welcome clarification. It gives acquirers a clearer path for certain transactions and reduces uncertainty around deals involving nascent technologies or pre-revenue targets.
The shield has limits. It does not apply to the largest players in a market, or to gatekeepers. But that does not mean gatekeepers cannot acquire start-ups. It means they will not benefit from the presumption and will face a fuller assessment. The distinction matters. It is not a prohibition. It is a burden shift.
What This Means Going Forward
The new guidelines are an opportunity for lawyers who understand the full picture.
The Commission is not asking for better legal arguments alone. It is asking for a deeper understanding of the business, the competitive dynamics, and the financial signals behind the transaction.
The increased flexibility in the framework will require more economic analysis. And lawyers who can bridge the gap between that analysis and a credible legal argument will be better placed to use the tools the new guidelines offer.
The business model was always relevant. The Commission has now said so explicitly.
